Opioid Use Disorder Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2022-2032), Analyzes DelveInsight | Key Companies - Braeburn Pharmaceuticals, BioXcel Therapeutics, Braeburn Pharmaceuticals, Alkermes, Inc., Indivior Inc.

DelveInsight's "Opioid Use Disorder Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Opioid Use Disorder, historical and forecasted epidemiology as well as the Opioid Use Disorder market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

To Know in detail about the Opioid Use Disorder market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Opioid Use Disorder Market Forecast
https://www.delveinsight.com/report-store/opioid-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Opioid Use Disorder Market Report:
• The Opioid Use Disorder market size was valued approximately USD 1970 Million in 2022 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
• In December 2022, The resubmitted New Drug Application (NDA) for Brixadi (buprenorphine) extended-release weekly and monthly subcutaneous injection was approved by the US Food and Drug Administration (FDA) for the treatment of moderate to severe opioid use disorder in patients who started treatment with a single dose of a transmucosal buprenorphine product or who are already receiving buprenorphine treatment
• In 2022, among the 7MM, the United States accounted for the highest number of prevalent cases of OUD
• The EU4 and the UK countries accounted for ~1,453,000 cases in 2022 which will reach to increase by 2032
Among EU4 and the UK countries, Spain had the lowest number of prevalent cases of Opioid Use Disorder at ~87,000 cases in 2022. As per DelveInsight's estimates, these are expected to increase by 2032
• In 2022, as per severity of Opioid Use Disorder; mild, moderate and severe cases formed 65%, 19% and 16% of the total prevalent cases of Opioid Use Disorder in the US, respectively
• Key Opioid Use Disorder Companies: Braeburn Pharmaceuticals, BioXcel Therapeutics, Braeburn Pharmaceuticals, Alkermes, Inc., Indivior Inc., Braeburn Pharmaceuticals, Evon Medics LLC, and others
• Key Opioid Use Disorder Therapies: CAM2038, BXCL501, CAM2038, NTX/BUP, SUBOXONE, CAM2038, CBOT + TAU, and others
• The Opioid Use Disorder market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Opioid Use Disorder pipeline products will significantly revolutionize the Opioid Use Disorder market dynamics.

Opioid Use Disorder Overview
Opioid use disorder is the chronic use of opioids that causes clinically significant distress or impairment. Opioid use disorder consists of an overpowering desire to use opioids, increased opioid tolerance, and withdrawal syndrome when discontinued.

Get a Free sample for the Opioid Use Disorder Market Report -
https://www.delveinsight.com/sample-request/opioid-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Opioid Use Disorder Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Opioid Use Disorder Epidemiology Segmentation:
The Opioid Use Disorder market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Opioid Use Disorder
• Prevalent Cases of Opioid Use Disorder by severity
• Gender-specific Prevalence of Opioid Use Disorder
• Diagnosed Cases of Episodic and Chronic Opioid Use Disorder

Download the report to understand which factors are driving Opioid Use Disorder epidemiology trends @ Opioid Use Disorder Epidemiology Forecast
https://www.delveinsight.com/sample-request/opioid-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Opioid Use Disorder Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Opioid Use Disorder market or expected to get launched during the study period. The analysis covers Opioid Use Disorder market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Opioid Use Disorder Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Opioid Use Disorder Therapies and Key Companies
• CAM2038: Braeburn Pharmaceuticals
• BXCL501: BioXcel Therapeutics
• CAM2038: Braeburn Pharmaceuticals

Discover more about therapies set to grab major Opioid Use Disorder market share @ Opioid Use Disorder Treatment Market
https://www.delveinsight.com/sample-request/opioid-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Opioid Use Disorder Market Strengths
• After the US recognized its opioid crisis and addressed it, there has been a surge in awareness and overall funding for research and development regarding opioid use disorder
• Although there have been only a few active ingredients proven to be effective in the treatment of OUD, their different and innovative formulations have revolutionized the treatment landscape by significantly improving treatment adherence among patients and preventing relapses

Opioid Use Disorder Market Opportunities
• Removal of the DATA 2000 waiver and cap on how many patients can be treated with buprenorphine by a physician is set to transform the treatment landscape of OUD in the US, further increasing the usage of buprenorphine in the treatment setting
• Upcoming policy changes are expected to further improve access to MOUD for OUD patients and improve their usage in the treatment setting

Scope of the Opioid Use Disorder Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Opioid Use Disorder Companies: Braeburn Pharmaceuticals, BioXcel Therapeutics, Braeburn Pharmaceuticals, Alkermes, Inc., Indivior Inc., Braeburn Pharmaceuticals, Evon Medics LLC, and others
• Key Opioid Use Disorder Therapies: CAM2038, BXCL501, CAM2038, NTX/BUP, SUBOXONE, CAM2038, CBOT + TAU, and others
• Opioid Use Disorder Therapeutic Assessment: Opioid Use Disorder current marketed and Opioid Use Disorder emerging therapies
• Opioid Use Disorder Market Dynamics: Opioid Use Disorder market drivers and Opioid Use Disorder market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Opioid Use Disorder Unmet Needs, KOL's views, Analyst's views, Opioid Use Disorder Market Access and Reimbursement

To know more about Opioid Use Disorder companies working in the treatment market, visit @ Opioid Use Disorder Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/opioid-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Opioid Use Disorder Market Report Introduction
2. Executive Summary for Opioid Use Disorder
3. SWOT analysis of Opioid Use Disorder
4. Opioid Use Disorder Patient Share (%) Overview at a Glance
5. Opioid Use Disorder Market Overview at a Glance
6. Opioid Use Disorder Disease Background and Overview
7. Opioid Use Disorder Epidemiology and Patient Population
8. Country-Specific Patient Population of Opioid Use Disorder
9. Opioid Use Disorder Current Treatment and Medical Practices
10. Opioid Use Disorder Unmet Needs
11. Opioid Use Disorder Emerging Therapies
12. Opioid Use Disorder Market Outlook
13. Country-Wise Opioid Use Disorder Market Analysis (2019-2032)
14. Opioid Use Disorder Market Access and Reimbursement of Therapies
15. Opioid Use Disorder Market Drivers
16. Opioid Use Disorder Market Barriers
17. Opioid Use Disorder Appendix
18. Opioid Use Disorder Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:
Opioid Use Disorder Epidemiology https://www.delveinsight.com/report-store/opioid-use-disorder-oud-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Opioid Use Disorder Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Opioid Use Disorder epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight
Scedosporium Infection Market https://www.delveinsight.com/report-store/scedosporium-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Scedosporium Infection Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Scedosporium Infection, historical and forecasted epidemiology as well as the Scedosporium Infection market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Vascular Graft Devices Market https://www.delveinsight.com/report-store/vascular-grafts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2027 owing to increasing prevalence of cardiovascular diseases such as aortic aneurysms and peripheral artery disease and growing patient for kidney dialysis.

Vascular Stents Market https://www.delveinsight.com/report-store/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Vascular Stents Market By Product Type (Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, Femoral Stents, Other], Evar Stent Grafts [Abdominal Aortic Aneurysm Stents, Thoracic Aortic Aneurysm Stents]), By Type (Bare-Metal Stents, Drug-Eluting Stents), By Material (Metal And Polymer), By Mode Of Delivery (Balloon-Expandable Stents And Self Expandable Stents), By End-User (Hospitals And Ambulatory Surgical Centers), by geography, is expected to grow at a noteworthy CAGR forecast till 2027 owing to rising burden of vascular diseases across the globe and increasing preferences of minimally invasive surgeries among the patient population.

Vein Illumination Devices Market https://www.delveinsight.com/report-store/vein-illumination-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Vein Illumination Devices Market Insight, Competitive Landscape and Market Forecast, 2027" report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Bladder Scanners Market https://www.delveinsight.com/report-store/bladder-scanners-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Bladder Scanners Market Insight, Competitive Landscape and Market Forecast, 2027" report delivers an in-depth understanding of Bladder Scanners and the historical and forecasted Bladder Scanners market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Recent Blog's By DelveInsight:

• Insights Into The Cutaneous T-cell Lymphoma Treatment Market
https://www.delveinsight.com/blog/cutaneous-t-cell-lymphoma-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Roche's HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
https://www.delveinsight.com/blog/hemlibra-for-hemophilia-a-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Emerging Role of Digital Health in the Field of Oncology
https://www.delveinsight.com/blog/digital-health-to-improve-cancer-management?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
https://www.delveinsight.com/blog/evolving-als-treatment-landscape?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How are Technological Trends and Innovations Reshaping the Dementia Care
https://www.delveinsight.com/blog/technological-innovations-in-dementia-care?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
https://www.delveinsight.com/blog/clinical-diagnostics-market-outlook?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
https://www.delveinsight.com/blog/non-opioid-analgesics-for-chronic-pain-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
https://www.delveinsight.com/blog/alpha-1-antitrypsin-deficiency-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Evaluating the Key Trends and Technologies Shaping the Future of Dentistry https://www.delveinsight.com/blog/emerging-trends-in-dental-care-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr

Media Contact

Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.